Summit Therapeutics (SMMT) Fails to deliver data

Key failure to deliver metrics for Summit Therapeutics :

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: £1.31 M
• Last 3 months FTD volume: £5.4 M
• Last 12 months FTD volume: £0.31 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Summit Therapeutics (SMMT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Summit Therapeutics (SMMT) - since 2020

Summit Therapeutics (SMMT) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sarepta Therapeutics SRPT	£5.28 M	£23.03 M	🇺🇸 USA
Merrimack Pharmaceuticals MACK	N/A	£4.65 M	🇺🇸 USA
Coherus BioSciences CHRS	£2.99 M	£5.94 M	🇺🇸 USA
Arena Pharmaceuticals ARNA	N/A	£0.21 B	🇺🇸 USA